Research Now Highlights One Technique to Prevent Antimicrobial Resistance

(Newswire.net — April 14, 2022) Orlando, FL — Antibiotic resistance is considered to be a global growing health threat. This is why experts increasingly study the ways to reduce its rates and prevent it from taking more lives.

A new analysis carried out by the researchers of the University of California, Berkeley has shown that childhood vaccination proves to be a powerful tool in battling antimicrobial resistance in low- and middle-income countries.

Around the globe, overuse of antibiotics is fuelling the proliferation of bacterial “superbugs” that have been found to evolve for the purpose of surviving antimicrobial exposure. This makes humans more vulnerable to certain diseases, such as malaria, sepsis, tuberculosis, and pneumonia. 

The new study has shown that immunization with two common vaccines significantly lessens the rates of acute respiratory infections and diarrhea among children. These two vaccines are the pneumococcal conjugate and rotavirus vaccines.

Further through the vaccines, fewer children got sick or severely sick and this means fewer were also receiving antibiotic treatment.

“Right now, almost all countries have developed or are in the process of developing national action plans to address the crisis that antibiotic resistance poses to their health systems, but there is very little evidence addressing which interventions are effective,” said Joseph Lewnard, an assistant professor of epidemiology at UC Berkeley, and lead author of the paper. 

“By providing hard numbers on the substantial impact that has been achieved with just these two vaccines alone, our work demonstrates that vaccines should be among the interventions that are strongly prioritized.”

The study was the first to look into the link between vaccination and the use of antibiotics in low- and middle-income settings.

Its findings were published in the Nature journal. 

“We’re not accounting for the fact that there are indirect reductions in disease associated with declining transmission of the pathogens themselves, and that there might be additional benefits in other age groups as well,” Lewnard said. 

“Moreover, we are looking at a narrow spectrum of all pneumococcal diseases, which, further, include ear infections and sinusitis cases that often receive antibiotic treatment.”

Individuals with UTIs who want to reduce their risk of antibiotic resistance may lessen their susceptibility to the infection through the use of a UTI-fighting sugar called D-mannose.

To benefit from the therapeutic goodness of this UTI-fighting ingredient, it is wise to consider the use of Divine Bounty D-mannose. It is one of the most effective and powerful D-mannose formulas available. 

It offers an incredible 600mg of D-mannose plus cranberry and dandelion extracts in just one capsule and is used widely today by individuals who are trying to combat UTIs. Every bottle even offers 120 Vegetarian and easy-to-swallow capsules and is backed with a customer satisfaction guarantee.  

It is also GMO-free, soy-free, gluten-free, and has no preservatives, stearates, silicon dioxide, or artificial ingredients (http://www.amazon.com/D-Mannose-600mg-Cranberry-Dandelion-Extract/dp/B01LX5KGF0).